Term
what are the 3 categories of myeloid neoplasms |
|
Definition
acute myeloid leukemias myeloproliferative disorders myelodysplastic syndromes |
|
|
Term
what are the 4 types of AML |
|
Definition
acute prolyelocytic leukemia acute monocytic leukemia acute megakaryoblastic leukemia myelodysplastic syndrome |
|
|
Term
what are the 4 myeloproliferative disorders |
|
Definition
chronic myeloid leukemia polycythemia vera primary myelofibrosis essential thrombocythemia |
|
|
Term
what is the general cellular process that leads to the symptoms in AML |
|
Definition
blast cells are unable to differentiate causing accumulation in the marrow
blasts crowd out normal hematopoiesis causing anemia, thrombocytopenia, and neutropenia. evuntally lead to marrow failure
blasts enter blood and and increase WBC count with large, immature (little cytoplasm) cells with punched out nucleolus |
|
|
Term
what are the general clinical signs of AML 5 |
|
Definition
>55yo abrupt onset: present within 3mo depression of marrow function: fatigue, bleeding, fever, pallor, infection bone pain and tenderness: marrow expansion, sub-periostral infiltration
if mass, will be discrete and granulocytic |
|
|
Term
lab signs that distinguish AML 8 |
|
Definition
GRANULOCYTIC DIFFERENTIATION: MYELOPEROXIDASE AZUROPHILIC GRANULES IN AUER ROD CRYSTALIZATIONS
lysosomal non-specific esterase positive
blasts in peripherial blood and marro WBC<10000 or >100000
anemia, neutropenia, thrombocytopenia <100000 platelets0
acute leukemia: rare occurance where there is no blasts in blood
CD33: myeloid progenetor marker (also CD64, CD117, CD13-15) |
|
|
Term
4 characteristics of a AML on a wright gemisa stain |
|
Definition
fine chromatin more cytoplasm more granules peroxidase positive |
|
|
Term
cause of acute prolyeocytic leukemia |
|
Definition
t(15l17) fuses RARA-PML blocking myeloid differentiation due to TF mutation |
|
|
Term
TX prolyelocytic leukemia 3 |
|
Definition
take care of DIC first: EMERGENCY auer rods cause DIC
retinoic acid (vitA): overcomes block making neutrophiles and clearing tumor cells
chemo: use this too or pt will relapse |
|
|
Term
prognosis of acute prolyelocytic leukemia |
|
Definition
|
|
Term
how is acute monocytic leukemia diagnosed in the lab |
|
Definition
positive for myeloperoxidase |
|
|
Term
clinical signs of acute monocytic leukemia and why |
|
Definition
proliferation of monoblasts that infiltrate gums causing ulceration and swelling |
|
|
Term
2 diagnostic criteria/associations for acute megakaryoblastic anemia |
|
Definition
lack myeloperoxidase associated with down syndrom <5yo |
|
|
Term
cause of myelodysplastic syndrome (AML) |
|
Definition
exposure to alkylating agents or radiotherapy causes dysplasia of marrow cells, they are not permitted to enter the blood causing cytopenia and hypercellular marrow |
|
|
Term
prognosis of myelodysplastic syndrome (AML) 2 |
|
Definition
death due to infection of bleeding 20% progress to acute leukemia |
|
|
Term
general prognosis for AML 2 |
|
Definition
50% have long term disease 30% have long term disease with chemo could benifit from marrow transplant |
|
|
Term
risk factors for myelodysplastic syndrome 4 |
|
Definition
chemotherapy alkylating agents ionizing radiation idiopathic |
|
|
Term
explain the cellular changes in myelodysplastic syndrome |
|
Definition
damage from risk factors causes loss of 5q or 7q which causes dysplasia in marrow cells and the marrow is replaced by transformed multipotential stems cells that can differentiate into RBC, granulocytes, platelets that are ineffective |
|
|
Term
clinical signs of myelodysplastic syndrome 3 |
|
Definition
|
|
Term
3 signs in the marrow of myelodysplastic syndrome |
|
Definition
hyper or normocellular megaloblastic erythroid precursors with Fe deposits in mitochondria (ringed sideroblasts) granuulocyte precursors with abnormal granules |
|
|
Term
prognosis of myelodysplastic syndrome 3 |
|
Definition
stem cells in marrow are unstable and could get mutations transforming it to AML
poor response to chemotherapy
mean survival 9-20mo |
|
|
Term
general cause and cellular changes in chronic myeloproliferative disorders |
|
Definition
proliferation of myeloid progenitors that can terminally differentiate
involve activation of TK which generate signs mimicing hematopoietic GF |
|
|
Term
clinical signs of chronic myeloproliferative disorders 4 |
|
Definition
later adult high WBC hypercellular marrow
may SEED nodes, liver, spleen (they make cancer too!) causing HSM and lymphadenopathy
hyperuricemia/gout: WBC break down products compete with uric acid
marrow fibrosis: marrow burns out, this causes transfer to acute leukemia |
|
|
Term
cause of chronic myeloid leukemia |
|
Definition
95% t(9;22/phildalphia) fusion of BCR-ABL increases TK which mimics growth factors and causes a proliferation of GRANULOCYTES
5% subcytogenic BCR-ABL fusion along with other CH translocations |
|
|
Term
clinical signs and stages 3 of CML |
|
Definition
pt 25-60yo slow onset, non-specific symptoms
1. chronic: MASSIVE splenomeagly from extramedullary hematopoesis
2. accelerated: currently enlarging spleen, anemia, thrombocytopenia (only 50% have this phase)
3. transofrmation/blast crisis: transformation to acute leukemia (70%AML, 30%ALL) |
|
|
Term
|
Definition
leukocytosis >100000 (BASOPHILIA, neutrophils, myelocytes, metamyelocytes)
thrombocytosis
marrow hypercellularity
red pulp enlargement in spleen
leukocyte alkaline phosphatase LOW
t(9;22) ABL-BCR |
|
|
Term
|
Definition
marrow transplant: 70% curative, high risk TK inhibitors |
|
|
Term
|
Definition
|
|
Term
cause of polycythemia vera |
|
Definition
JAK2 TK mutation activates EPO precursors increasing RBC |
|
|
Term
clinical signs of polycythemia vera 17 |
|
Definition
middle age slow onset organ congestion and cyanosis: flushed face, HSM extramedullary hematopoesis: HSM thrombosis/infarct: heart, spleen, kidney hemorrhage: GI, oropharynx, brain headache dizziness hematemesis melena blurry vision gout/hyperuricemia |
|
|
Term
how do you distinguish polycythemia very from reactive and absolute polycythemia |
|
Definition
reactive: SaO2 increase absolute: EPO increase vera: no SaO2 increase, decreased EPO |
|
|
Term
lab signs of polycythemia vera 4 |
|
Definition
decreased EPO basophilia HVT 60% hypercellular marrow (progresses to spend with fibrosis leadiing to AML) |
|
|
Term
tx of polycythemia vera 2 |
|
Definition
phelbotomy: decreased RBC mass hydroxyurea |
|
|
Term
prognosis of polycythemia vera 3 |
|
Definition
death w/o tx in 1y - vascular complications 10y survival - with phlebotomy
marrow failure --> AML |
|
|
Term
cause of primary myelofibrosis |
|
Definition
JAK2 TK mutation increases megakaryocyte production
this crowds out and spends the marrow and shifts hematopoesis to spleen, liver, nodes causing HSM, anemia, thrombocytopenia, mild neutropenia |
|
|
Term
clinical signs of primary myelofibrosis 5 |
|
Definition
HSM: once marrow fibrosed hematopoesis occurs in spleen, liver and nodes
increased infection, thrombosis, bleeding
hyperuricemia/gour |
|
|
Term
why is there such fast fibrosis of marrow in primary myelofibrosis |
|
Definition
megakaryocyte (platelet precursor) overproduction --> increased PDGF and TGFb which turn on fibroblasts in marrow |
|
|
Term
lab signs in primary myelofibrosis marrow biopsy 6 |
|
Definition
fibroblasts neoplastic megakaryocytes abnormal RBC in odd shapes leukoerythroblastosis initially hypercellular with megakaryocytes later hypocellular with fibrosis |
|
|
Term
lab signs in blood biopsy in primary myelofibrosis |
|
Definition
abnormal RBC in odd shapes: PLIKILOCYTES, TEAR DROP RBC
immature WBC: leukoerythroblastosis, basophilia
large platelets: due to extramedullary hematopoesis
leukoerythroblastic smear |
|
|
Term
what is leukoerythroblastosis |
|
Definition
myelocytes and metamyelocytes |
|
|
Term
what is a leukoerythroblastic smear |
|
Definition
marrow contains reticulin gates to stop immature cells but in the spleen there are none so when it takes over hematopoesis (primary myelofibrosis) you seen myelocytes and metamyelocytes in the blood(nucleated RBC) |
|
|
Term
primary myelofibrosis prognosis |
|
Definition
CML transformation survive 4-5y 5-15% AML transformation |
|
|
Term
what are langerhans cells, what do they do |
|
Definition
immature dendritic skin cells derived from marrow monocytes that present antigen to nieve T cells |
|
|
Term
cause of langerhans cells histocytosis |
|
Definition
HLA-DR and CD1a cause neoplastic proliferation of langerhans cells that look histocytic rather than dendritic |
|
|
Term
morphological characteristics of langerhans cells histocytosis 7 |
|
Definition
birbeck/tennis racket/HX bodies in cytoplasm (granules)
HLA-DR, MHC-II, CD1a, langerhin and S100 positive vaculated cytoplasm |
|
|
Term
what are the three langerhan cell histocytosis deasases |
|
Definition
letterer-swie disease (multisystem langerhands cell histocytosis/acute disseminated langerhans cell histocytosis)
eosinophilic granuloma (unifocal and multifocal langerhan cell histocytosis)
hans-schuller-christian disease |
|
|
Term
clinical signs of letterer swie disease 10 |
|
Definition
<2yo srborrhetic like erruptions multifocal
if severe.. lymphadenopathy pulmonary lesions osteolytic bone lesions HSM marrow infiltration: pancythemia (recurrent otitis media and mastoiditis) |
|
|
Term
tx and prognosis of letterer swie disease |
|
Definition
MALIGNANT intense chemotherapy rapidly fatal without tx 50% 5y survival with treatment |
|
|
Term
cause of eosinophilic granuloma |
|
Definition
expanding erosive accumulation of langerhans in medullary cavity of bones |
|
|
Term
sings of unifocal eosinophilic granuloma 4 |
|
Definition
adolescent skeletal lesions asymptomatic (pain, tenderness) pathological fracture: calvaria, ribs, femur |
|
|
Term
prognosis of unifocal eosinophilic granuloma 2 |
|
Definition
heal spontaneously cured with local excision or radiation |
|
|
Term
signs of multifocal eosinophilic granuloma 10 |
|
Definition
in kids multiple erosive bony lesions infiltrate soft tissue: skin, lungs, stomach diffuse skin erruptions: ears, scalp ototis media, mastoiditis, URI lymphadenopathy HSM 50% involve posterior stalk and cause DI |
|
|
Term
hans-schuller-christian disease clinical signs 4 |
|
Definition
lytic scalp defects DI exophalmos >3yo |
|
|
Term
hans-schuller-christian prognosis 2 |
|
Definition
spontaneous regression often cured with chemo |
|
|
Term
8 things that cause massive (>1000g) splenomeagly |
|
Definition
myeloproliferative disorders: CML, primary myelofibrosis
chronic lymphocytic leukemia hairy cell leukemia lymphoma malaria gauchers primary spleen tumor |
|
|
Term
13 things that cause moderate (500-1000g) splenomeagly |
|
Definition
portal HTN splenic vein obstruction acute leukemia hereditary spherocytosis thalassemia major autoimmune hemolytic anemia amyloidosis neimann pick metastic carcinoma/sarcoma splenitis TB sarcoidosis typhoid |
|
|
Term
6 things that cause mild (<500g) splenomeagly |
|
Definition
acute splenitis mono septicemia intra abdominal infection acute spleen congestion SLE |
|
|
Term
|
Definition
enlarged spleen due to removal of excess circulation formed blood elements
most common and serious is platelets second is RBC and PMN |
|
|
Term
cause of thymic hyperplasia |
|
Definition
lymphoid follicles (germinal centers) in medulla with reactive B cells
present with myasthenia gravis, SLE, other autoimmune diseases |
|
|
Term
|
Definition
neoplastic proliferation of thymic epithelial cells |
|
|
Term
what does a thymoma look like: size, texture, color, location, cells around it |
|
Definition
firm and lobulated white gray 15-20cm encapsulated in perithymic tissue non-neoplastic thymocytes (immature T cells) by it |
|
|
Term
what are the three types of thymoma, describe their cytological and biological agressiveness |
|
Definition
60% benigh: cytologically and biologicallt benign
20% malignant type I: cytologically benign, biologically malignant
5% malignant type II - cytologically and biologically malignant |
|
|
Term
describe the cells in a benign thymoma |
|
Definition
medullary thymoma: spindled, elongated, medulla like
mixed thymoma: plump, round, cortical like |
|
|
Term
where is the malignant 1 thymoma located |
|
Definition
locally invasive, occasionally metastasize penetrates capsule and invades surroundiing vessels |
|
|
Term
describe the epithelial cells of a malignant 1 thymoma |
|
Definition
abundant cytoplasm round vasicular nuclei some spindled epithelial cells |
|
|
Term
what does a malignant 2 thymoma look like |
|
Definition
|
|
Term
what tumors does malignant 2 thymoma behave like |
|
Definition
squamous cell carcinoma or lymphoepithelioma like carcinoma |
|
|
Term
what two cellular characteristics does malignant 2 thymoma have |
|
Definition
EBV genome included many tymocytes around it |
|
|